Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A Phase I randomized controlled trial-Reference-Cited by-同舟云学术

Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A Phase I randomized controlled trial

Published:2016-08 Issue: Volume:61 Page:63-71
ISSN:1525-5050
Container-title:Epilepsy & Behavior
language:en
Short-container-title:Epilepsy & Behavior

Author:

Levy-Cooperman Naama,Schoedel Kerri A.,Chakraborty Bijan,Blum David,Cheng Hailong

Funder

Sunovion Pharmaceuticals Inc.

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Neurology (clinical),Neurology

Reference30 articles.

1. Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects;Almeida;J Clin Pharmacol,2005

2. Inhibitory effects of eslicarbazepine acetate and its metabolites against neuronal voltage-gated sodium channels;Hebeisen;Epilepsia,2011

3. Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy;Ben-Menachem;Epilepsy Res,2010

4. Efficacy of eslicarbazepine acetate in patients with refractory partial onset seizures: a pooled analysis of three phase III controlled studies;Biton;Epilepsy Curr,2014

5. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study;Elger;Epilepsia,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Cognitive Effects of the Dual Orexin Receptor Antagonist Lemborexant Compared With Suvorexant and Zolpidem in Recreational Sedative Users;Journal of Clinical Psychopharmacology;2022-06-24

2. Adolescents’ Understanding of Opioid-Induced Euphoria Measures and Proposed Measurement Revisions;Journal of Psychoactive Drugs;2021-08-06

3. New and Emerging Antiepileptic Drugs;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

4. Eslicarbazepine Acetate: A Review in Focal-Onset Seizures;CNS Drugs;2020-07-31

5. Randomized Crossover Trial to Compare Abuse Liability of Intravenous Remimazolam Versus Intravenous Midazolam and Placebo in Recreational Central Nervous System Depressant Users;The Journal of Clinical Pharmacology;2020-06-03